Propranolol

BreastfeedingPediatric
  • TRADE NAMES: Angilol; Apo-Propranolol; Apsolol; Detensol; Hemangeol (Pierre Fabre); Inderal (Wyeth); Inderal LA; Innopran XL
  • INDICATIONS: Hypertension, angina pectoris, atrial fibrillation, myocardial infarction, migraine, tremor, infantile hemangioma
  • CLASS: Antiarrhythmic, Antiarrhythmic class II, Beta adrenergic blocker, Beta blocker
  • HALF-LIFE: 2–6 hours

Cutaneous side effects of beta-receptor blockers are clinically polymorphous. They apparently appear after several months of continuous therapy.

Our database has 119 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
NAILS.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RENAL.
RESPIRATORY.
OTHER.


Page last updated 04/15/2020

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top